Data / Form D filings / Benten BioServices, Inc.
Benten BioServices, Inc.: Form D filings
Benten BioServices, Inc., a biotechnology company in Malvern, PA, filed 6 Form D notices with the SEC between 2012 and 2013. The latest, on May 15, 2013, reports $78,500 sold of a $250,000 offering to 6 investors.
Find out what Benten BioServices, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 347 PHOENIXVILLE PIKE, Malvern, PA, 19355
- Phone
- (610) 854-4700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1538610
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2013 | New notice | $250,000 | $78,500 | $171,500 | 6 | Apr 30, 2013 | sec.gov |
| Feb 1, 2013 | Amendment | $1,360,000 | $1,315,000 | $45,000 | 5 | Sep 20, 2012 | sec.gov |
| Oct 4, 2012 | New notice | $1,100,000 | $1,100,000 | $0 | 3 | Sep 20, 2012 | sec.gov |
| Aug 22, 2012 | New notice | $5,000,000 | $2,944,323 | $2,055,677 | 19 | Aug 14, 2012 | sec.gov |
| Jul 18, 2012 | Amendment | $2,775,000 | $2,739,500 | $35,500 | 17 | Dec 21, 2011 | sec.gov |
| Jan 4, 2012 | New notice | $2,275,000 | $1,275,000 | $1,000,000 | 12 | Dec 21, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paula Z. MacDonald | Executive Officer, Director | |
| Warren Chaunce Bogard | Director | |
| Bernard Chaunce Rudnick | Director | |
| Thomas Chaunce Penn | Director | |
| Michele Chaunce Washko | Director | |
| David Chaunce McLachlan | Director |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of May 13, 2013 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Benten BioServices, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.